A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures

eClinicalMedicine - Tập 38 - Trang 101001 - 2021
Cécile Tran Kiem1,2, Clément R. Massonnaud3,4, Daniel Levy-Bruhl5, Chiara Poletto6, Vittoria Colizza6, Paolo Bosetti1, Arnaud Fontanet7,8, Amélie Gabet5, Valérie Olié9, Laura Zanetti10, Pierre-Yves Boëlle6, Pascal Crépey3, Simon Cauchemez1
1Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, 25-28 rue du Dr Roux, 75015 Paris, France
2Sorbonne Université, Paris, France
3Univ Rennes, EHESP, REPERES « Recherche en Pharmaco-Epidémiologie et Recours aux Soins », EA 7449 Rennes, France
4Centre Hospitalier Universitaire de Rouen, Département d'Informatique Médicale, D2IM, Rouen, France
5Santé publique France, Saint Maurice, France
6INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France
7Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
8PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France
9Santé publique France, Saint-Maurice, France
10Haute Autorité de Santé, Saint-Denis La plaine Stade de France, France

Tài liệu tham khảo

O'Driscoll, 2021, Age-specific mortality and immunity patterns of SARS-CoV-2, Nature, 590, 140, 10.1038/s41586-020-2918-0

Bubar, 2021, Model-informed COVID-19 vaccine prioritization strategies by age and serostatus, Science, 10.1126/science.abe6959

Matrajt, 2020, Vaccine optimization for COVID-19: who to vaccinate first?, Sci Adv, 7

Moore, 2021, Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study, Lancet Infect Dis, 10.1016/S1473-3099(21)00143-2

Sandmann, 2021, The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation, Lancet Infect Dis, 10.1016/S1473-3099(21)00079-7

Salje, 2020, Estimating the burden of SARS-CoV-2 in France, Science, 369, 208, 10.1126/science.abc3517

Verity, 2020, Estimates of the severity of coronavirus disease 2019: a model-based analysis, Lancet Infect Dis, 20, 669, 10.1016/S1473-3099(20)30243-7

Reilev, 2020, Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort, Int J Epidemiol, 10.1093/ije/dyaa140

Ko, 2020, Risk factors for COVID-19-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system, Clin Infect Dis

Hall, 2021, Effectiveness of BNT162b2 mRNA vaccine against infection and COVID-19 vaccine coverage in healthcare workers in England

Thompson, 2021, MMWR Morb Mortal Wkly Rep, 70, 495, 10.15585/mmwr.mm7013e3

Jentsch, 2021, Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study, Lancet Infect Dis, 10.1016/S1473-3099(21)00057-8

Balicco, 2017, Protocole Esteban : une Étude transversale de santé sur l’environnement, la biosurveillance, l’activité physique et la nutrition (2014–2016), Toxicol Anal Clin, 29, 517

Kim, 2020, Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the U.S. coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET), Clin Infect Dis

Viner, 2020, Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis, JAMA Pediatr

Davies, 2020, Age-dependent effects in the transmission and control of COVID-19 epidemics, Nat Med, 26, 1205, 10.1038/s41591-020-0962-9

Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577

Voysey, 2021, Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials, Lancet, 397, 881, 10.1016/S0140-6736(21)00432-3

Baden, 2021, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, N Engl J Med, 384, 403, 10.1056/NEJMoa2035389

Amit, 2021, Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients, Lancet, 397, 875, 10.1016/S0140-6736(21)00448-7

Tande, 2021, Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening, Clin Infect Dis

Gaymard, 2021, Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021, Euro Surveill, 26, 10.2807/1560-7917.ES.2021.26.9.2100133

Davies, 2021, Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England, Science, 10.1126/science.abg3055

Volz, 2021, Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England, Nature, 1

Flaxman, 2020, Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe, Nature, 584, 257, 10.1038/s41586-020-2405-7

Voysey, 2021, Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, Lancet, 397, 99, 10.1016/S0140-6736(20)32661-1

Santé Publique France. COVID-19 : point épidémiologique du 25 mars 2021. 2021 https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-25-mars-2021 (Accessed March 27, 2021).

Davies, 2021, Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7, Nature, 10.1038/s41586-021-03426-1

Zhou, 2021, Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, Cell

Finlay, 2021, Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021, Euro Surveill, 26

Ayoubkhani, 2021, Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study, BMJ, 372, n693, 10.1136/bmj.n693

Persad, 2009, Principles for allocation of scarce medical interventions, Lancet, 373, 423, 10.1016/S0140-6736(09)60137-9

Williams, 2021, How should we conduct pandemic vaccination?, Vaccine, 39, 994, 10.1016/j.vaccine.2020.12.059

Thông tin
Thông tin xuất bản

eClinicalMedicine

Tập 38

101001

Thông tin tác giả